Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development
Article excerpt
Highlighted: the sentence this signal was extracted from
New industry collaboration addresses pharma's most complex development challenges and expedites patient access to breakthrough therapies MILWAUKEE, Oct. 8, 2026 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK ), the world's largest company dedicated to industrial automation and digital transformation, today announced it is a founding member of the Digital CMC Consortium , a not-for-profit, pre-competitive industry collaboration focused on advancing digital standards and infrastructure to accelerate drug development. Pharmaceutical companies face growing pressure to accelerate development timelines and manage rising costs while meeting complex regulatory requirements. Yet Chemistry, Manufacturing and Controls (CMC) activities, which define how a drug is developed, manufactured, tested and controlled to ensure quality, remain a longstanding bottleneck in drug development due to manual, document-based workflows and a lack of process standardization. As therapies become more complex and personalized, CMC activities must evolve into structured, digital systems that accelerate technology transfer and enable seamless knowledge sharing and data-driven decision-making. The Consortium brings together industry leaders across the CMC ecosystem - pharmaceutical organizations, biotechnology firms, contract development and manufacturing organizations (CDMOs), technology providers and...
Keep reading with a free account
The rest of this article, and every signal for Rockwell Automation, is in your free account.
